To reduce the biases related to the inhomogeneity of patients, we decided to analyze only adult patients with a pathological diagnosis of IDH 1/2 wild-type glioblastoma and a KPS greater than 70, who were treated with post-operative radio-chemotherapy and temozolomide. This evidence concerns the gene IDH1 and glioblastoma.